Related Experiment Video

Updated: May 24, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Pediatric oncology in Pakistan

Muhammad Shamvil Ashraf1

  • 1Children Cancer Hospital, Karachi, Pakistan. shamvil@cyber.net.pk

Journal of Pediatric Hematology/Oncology
|February 24, 2012
PubMed

Insights

Pediatric oncology in Pakistan has seen significant growth in treatment facilities and expertise over the past decade. While challenges remain, more children now access quality cancer care, with pediatric palliative care in its early stages.

Area of Science:

  • Oncology
  • Pediatric Healthcare

Background:

  • Pediatric oncology in Pakistan has advanced significantly in the last decade.
  • There's an increased availability of treatment facilities and specialized expertise.
  • Despite progress, a portion of children still face barriers in accessing treatment centers.

Purpose of the Study:

  • To evaluate the development and current state of pediatric oncology services in Pakistan.
  • To highlight improvements in treatment access, nursing, and allied services.
  • To underscore the role of philanthropic support and specific institutions in advancing childhood cancer care.

Main Methods:

  • The study is based on a review of the development of pediatric oncology in Pakistan.
  • Analysis of the increase in treatment facilities and expertise.
  • Assessment of improvements in nursing and allied services.

Main Results:

  • Substantial increase in pediatric oncology facilities and expertise.
  • Improved access to quality cancer treatment for more children.
  • Gradual enhancement of pediatric oncology nursing and allied services.
  • Pediatric palliative care is in its nascent stages of development.
  • Philanthropic organizations play a crucial role in supporting pediatric oncology services.

Conclusions:

  • Pediatric oncology in Pakistan has made considerable progress over the last decade.
  • Increased access to quality cancer treatment and improved supportive services are evident.
  • Institutions like Children Cancer Hospital are vital for providing treatment, capacity building, and awareness for childhood cancer in Pakistan.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...